Vaccines
Feature
Survey: Acceptance of COVID-19 vaccine dips below 50%
Willingness to get such a vaccine has been steadily dropping since April.
Conference Coverage
Worldwide measles vaccination is flagging
Vaccine hesitancy and other factors are driving a resurgence in the disease, with short-term and long-term consequences.
Conference Coverage
Fauci: Cautious optimism for COVID-19 vaccine by end of 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.
From the Journals
Flu vaccine significantly cuts pediatric hospitalizations
More than half (58%) of hospitalized children had underlying medical conditions and 38% had at least one hospitalization in the past year.
From the Journals
HPV vaccination remains below Healthy People goals despite increases
HPV vaccination among U.S. adolescents has increased in the last decade but varies at state level.
Practice Alert
Prospects and challenges for the upcoming influenza season
New vaccine and antiviral products are available, and additional vaccine contraindications are identified. The concurrence of influenza and SARS-...
Conference Coverage
COVID-19 vaccine hesitancy ‘somewhat understandable,’ expert says
Dr. Offit predicts a vaccine may be able to be 75%-80% effective at preventing mild to moderate disease.
From the Journals
COVID-19 may discourage pediatric flu vaccination
Approximately one-third of parents whose children received no flu vaccine last year said the pandemic made them less likely to vaccinate their...
From the Journals
Shingrix effective in older adults with preexisting immune-mediated disorders
The most common immune-mediated disorders in two phase 3 clinical trials of the vaccine were psoriasis, spondyloarthropathy, rheumatoid arthritis...
From the Journals
HPV vaccine shown to substantially reduce cervical cancer risk
A review of more than 1 million girls/women vaccinated in 2006-2017 shows a substantial reduction in the risk for invasive cervical cancer.
Latest News
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose...